Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth M Williams

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Rheumatology|December 8, 2009
Hyperuricemia, cardiovascular disease, and the metabolic syndromePraveen L Indraratna, Kenneth M Williams, Garry G Graham, et al.
Technology in Cancer Research & Treatment|March 18, 2015
Evaluation of mathematical algorithms for automatic patient alignment in radiosurgeryKenneth M Williams, Reinhard W Schulte, Keith E Schubert, et al.
Clinical Rheumatology|January 9, 2016
Effect of xanthine oxidase inhibitors on the renal clearance of uric acid and creatinineDiluk R W Kannangara, Garry G Graham, Kenneth M Williams, et al.
The Canadian Journal of Cardiology|July 9, 2013
Hypouricemic effects of prednisone and allopurinol: an uneven playing field?Diluk R W Kannangara, Garry G Graham, Kenneth M Williams, et al.
Drug Safety|July 19, 2008
A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?Ming-Han H Lee, Garry G Graham, Kenneth M Williams, et al.
The Medical Journal of Australia|October 19, 2004
Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?Christine Y Lu, Kenneth M Williams, Lyn March, et al.
Clinical Pharmacokinetics|October 19, 2016
Clinical Pharmacokinetics and Pharmacodynamics of FebuxostatBishoy Kamel, Garry G Graham, Kenneth M Williams, et al.
European Journal of Clinical Pharmacology|December 25, 2010
Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteersDaniel Y Ng, Sophie L Stocker, Garry G Graham, et al.
Clinical Science (London, England : 1979)|November 1, 2016
Xanthine oxidoreductase and its inhibitors: relevance for goutRichard O Day, Bishoy Kamel, Diluk R W Kannangara, et al.
Clinical Pharmacokinetics|January 16, 2008
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjectsSophie L Stocker, Kenneth M Williams, Andrew J McLachlan, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Rheumatology|December 8, 2009
Hyperuricemia, cardiovascular disease, and the metabolic syndromePraveen L Indraratna, Kenneth M Williams, Garry G Graham, et al.
Technology in Cancer Research & Treatment|March 18, 2015
Evaluation of mathematical algorithms for automatic patient alignment in radiosurgeryKenneth M Williams, Reinhard W Schulte, Keith E Schubert, et al.
Clinical Rheumatology|January 9, 2016
Effect of xanthine oxidase inhibitors on the renal clearance of uric acid and creatinineDiluk R W Kannangara, Garry G Graham, Kenneth M Williams, et al.
The Canadian Journal of Cardiology|July 9, 2013
Hypouricemic effects of prednisone and allopurinol: an uneven playing field?Diluk R W Kannangara, Garry G Graham, Kenneth M Williams, et al.
Drug Safety|July 19, 2008
A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?Ming-Han H Lee, Garry G Graham, Kenneth M Williams, et al.
The Medical Journal of Australia|October 19, 2004
Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?Christine Y Lu, Kenneth M Williams, Lyn March, et al.
Clinical Pharmacokinetics|October 19, 2016
Clinical Pharmacokinetics and Pharmacodynamics of FebuxostatBishoy Kamel, Garry G Graham, Kenneth M Williams, et al.
European Journal of Clinical Pharmacology|December 25, 2010
Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteersDaniel Y Ng, Sophie L Stocker, Garry G Graham, et al.
Clinical Science (London, England : 1979)|November 1, 2016
Xanthine oxidoreductase and its inhibitors: relevance for goutRichard O Day, Bishoy Kamel, Diluk R W Kannangara, et al.
Clinical Pharmacokinetics|January 16, 2008
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjectsSophie L Stocker, Kenneth M Williams, Andrew J McLachlan, et al.
Pageof 7